Cassandra Pardini, PharmD

Contributing Writer https://www.empr.com

Cassandra Pardini is a freelance writer and registered pharmacist with a diverse background in drug therapy, scientific research, and the drug discovery and developmental process. She obtained her Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences University, Master of Science degree in chemistry and chemical biology from Northeastern University, and Bachelor of Science degree in chemistry from Boston College. She currently lives in Rhode Island with her husband and 3 children.

All articles by Cassandra Pardini, PharmD

News

Real-World Data Show Tdap Vaccination During Pregnancy Reduces Infant Pertussis Risk

Cassandra Pardini, PharmD

April 16, 2021

Tdap vaccination in the recommended 27–36-week window provides the largest benefit.

News

Graded Administration of Second COVID-19 Vaccine Dose After Hypersensitivity

Cassandra Pardini, PharmD

April 14, 2021

Current recommendations surrounding the administration of the second COVID-19 vaccine dose to patients who experience an immediate hypersensitivity reaction to the first dose are conflicting.

News

Medicare Claims Database Useful for Detecting Arrhythmogenic Risk of QT-Prolonging Drugs

Cassandra Pardini, PharmD

April 7, 2021

Study authors evaluated whether using an observational study that includes Medicare claims data could detect the proarrhythmic risk of medications known to prolong the QT interval.

News

Case Series: Naloxone Use Linked to Acute Pulmonary Edema

Cassandra Pardini, PharmD

April 6, 2021

At normal doses, the drug’s adverse effects are minimal, with the majority being attributed to acute withdrawal effects.

News

Ankle Sprain Treatment in the ED: Pain Med Trends Examined

Cassandra Pardini, PharmD

April 2, 2021

Overall, opioids were found to have accounted for the majority of medications used in the ED and prescribed at discharge.

News

CDC: Real-World Data Show mRNA COVID-19 Vaccines Highly Effective

Cassandra Pardini, PharmD

April 1, 2021

In this MMWR, interim estimates of the effectiveness of authorized mRNA vaccines in the prevention of symptomatic and asymptomatic SARS-CoV-2 infection in a real-world setting were discussed.

News

SGLT2 Inhibitor Use Linked to Reduced Risk of Atrial Arrhythmias in T2DM Patients

Cassandra Pardini, PharmD

March 25, 2021

This meta-analysis aimed to determine the association between SGLT2i use and arrhythmias in patients with T2DM or HF.

Uptravi Approved for Pulmonary Arterial Hypertension

News

FDA-Approved VEGFR Tyrosine Kinase Inhibitors Ranked by Cardiotoxic Potential

Cassandra Pardini, PharmD

March 25, 2021

Lenvatinib was associated with the most significant probability of producing all grades of cardiovascular injury and hypertension.

News

Rhythm-Control Therapy for New-Onset AF Associated With Sinus Rhythm Restoration in Critically Ill

Cassandra Pardini, PharmD

March 23, 2021

The analysis compared patients who received rhythm-control therapy for the treatment of new-onset AF to those who did not.

News

Case Report: Pain Med Dose Linked to Patient’s Sleepwalking

Cassandra Pardini, PharmD

March 23, 2021

The patient, who had suffered a traumatic brain injury approximately 8 months prior, presented to the emergency department complaining of increasing dizziness as well as sleepwalking frequency.